Unbiased AI-powered news
2 stories related to this topic, newest first.
ndtv.comThe Trump administration proposed altering a policy that prevents drugmakers from avoiding Medicare price negotiation by adding active ingredients to existing drugs. The change is part of an annual rule governing selection of the next 20 drugs and biologics for negotiation.
usatoday.comThe U.S. Supreme Court declined to hear challenges to the Medicare drug price negotiation program. The Maryland Prescription Drug Affordability Board agreed to set an upper payment limit for Ozempic. The White House expanded its TrumpRx discount platform with more than 600 generi…